China will create a system for drug patent disputes similar to the one in the U.S. Hatch-Waxman Act and allow for longer patent terms and higher damages under a revised law adopted last month. Here…
Featured Posts Title
China refuses to buy Nvidia’s AI chips after Trump’s tariff plan backfires
China eliminates tariffs on Africa to outmaneuver Trump
The 22nd China (Shenzhen) International Cultural Industries Fair (ICIF) kicked off in Shenzhen
Hidden tunnels, fake doors: China probes mining tragedy that killed 82
China’s world-beating solar industry is in turmoil
Beijing urges de-escalation after Russian threats to strike Kyiv
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
Recent Posts
4 Things To Know About China’s Revised Patent Law
China Telecom: Positive On Market Share Gains But Downside Risks Remain
China Telecom has gained market share in the Chinese mobile market at the expense of its competitors, as evidenced by its mobile service revenue growth and mobile subscriber net additions. ( read original story …)
Beijing Wants to Treat Ant Like a Bank and Its Value Hangs in the Balance
A growing regulatory assault on Ant is forcing a reassessment of how much the fintech giant is worth and whether the company’s growth will be crimped by Beijing in the years ahead. ( read original…
China’s central banker remind the global markets that the yuan’s challenge to the US dollar is still very much on
Success in the yuan’s internationalisation would give Chinese policymakers some things they’ve long dreamed about: the use of the renminbi as a global reserve currency and a challenge to the US dollar … ( read…
AstraZeneca’s COVID-19 vaccine to begin clinical trials in China: executive
AstraZeneca Plc plans to start early and mid-stage clinical trials of its COVID-19 vaccine candidate in China this year, a senior executive said on Friday, as it prepares a global rollout of the … (…
Australia says industry reports on China trade ‘deeply troubling’
Australia says it is closely monitoring trade flows to China amid “deeply troubling” reports from industry that Chinese buyers have been told not to purchase seven categories of Australian produce … ( read original story…
China bars arrivals from France over virus fears
Beijing on Thursday banned foreign arrivals from France and a host of other countries, the latest in a growing number of entry bans as China closes itself off from a world still battling the ……
What a Surprise the Size of Ant’s Halted IPO Say About China
In a shocking move this week, the much anticipated IPO of Ma’s Ant Group was put on hold. The $35 billion initial public offering would have been the biggest of all time and made the…
AstraZeneca’s COVID-19 vaccine to begin clinical trials in China-exec
AstraZeneca Plc plans to start early and mid-stage clinical trials of its COVID-19 vaccine candidate in China this year, a senior executive said on Friday, as it prepares a global rollout of the … (…
Farfetch, Alibaba, Richemont Join to Accelerate China Business
The three partners said they will bring luxury retail “to the next generation by seamlessly integrating the digital and physical realms.” … ( read original story …)
‘We surrender or walk away’: Readers respond to new trade concerns from China
For some readers commenting on the unfolding trade escalation with China, it was a case of “reap what you sow” for Australia. Other readers were clear Australia needed to stand its ground on foreign ……
Exclusive: GM Thinks Bigger in China With Plan to Import Full-Size SUVs
SHANGHAI (Reuters) – General Motors Co plans to sell full-size sport-utility vehicle (SUV) models in China for the first time, and will import a range of models to beef up its product lineup into the…
A Still-Divided U.S. Makes Confronting China Harder
The result of the presidential election is still unclear, but divided government—and a persistent U.S. political divide—could complicate attempts to shore up America’s economic leverage with Beijing. ( read original story …)
